Extract from the Register of European Patents

EP About this file: EP0552256

EP0552256 - METHOD OF TREATING OR PREVENTING TYPE 1 DIABETES BY ORAL ADMINISTRATION OF INSULIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.06.2002
Database last updated on 28.03.2026
Most recent event   Tooltip21.06.2002No opposition filed within time limitpublished on 07.08.2002  [2002/32]
Applicant(s)For all designated states
AUTOIMMUNE, INC.
Reservoir Office Park, 822 Boylston Street
Chestnut Hill, MA 02167 / US
[1993/30]
Inventor(s)01 / WEINER, Howard, L.
114 Somerset Road
Brookline, MA 02146 / US
02 / EISENBARTH, George
8 Summit Road
Wellesley, MA 02181 / US
03 / HAFLER, David, Allen
110 Forest Avenue
West Newton, MA 02165 / US
04 / ZHANG, Zhengri
130 Avon Street
Malden, MA 02148 / US
[1993/30]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [1993/30]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
D-80538 München / DE
Application number, filing date91918981.110.10.1991
[1993/30]
WO1991US07475
Priority number, dateUS1990059546810.10.1990         Original published format: US 595468
[1993/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9206704
Date:30.04.1992
Language:EN
[1992/10]
Type: A1 Application with search report 
No.:EP0552256
Date:28.07.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 30.04.1992 takes the place of the publication of the European patent application.
[1993/30]
Type: B1 Patent specification 
No.:EP0552256
Date:16.08.2001
Language:EN
[2001/33]
Search report(s)International search report - published on:US30.04.1992
(Supplementary) European search report - dispatched on:EP10.03.1994
ClassificationIPC:A61K38/28, A61K9/16, A61K9/50
[2000/14]
CPC:
A61K9/0053 (EP,US); A61K38/28 (EP,KR,US); A61K38/39 (EP,US);
A61K39/0008 (EP,US); A61K9/0073 (EP,US); A61P3/08 (EP);
A61P3/10 (EP); A61P37/00 (EP); A61K2039/541 (EP,US);
A61K2039/542 (EP,US); A61K2039/543 (EP,US); A61K38/00 (EP,US) (-)
Former IPC [1993/30]A61K37/26, A61K9/16, A61K9/50
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1993/30]
TitleGerman:METHODE ZUR BEHANDLUNG UND VORBEUGUNG VON TYP-1 DIABETIS DURCH ORALE VERABREICHUNG VON INSULIN[1993/30]
English:METHOD OF TREATING OR PREVENTING TYPE 1 DIABETES BY ORAL ADMINISTRATION OF INSULIN[1993/30]
French:METHODES SERVANT A TRAITER OU A PREVENIR LE DIABETE DU TYPE 1 PAR ADMINISTRATION ORALE D'INSULINE[1993/30]
Entry into regional phase08.04.1993National basic fee paid 
08.04.1993Search fee paid 
08.04.1993Designation fee(s) paid 
08.04.1993Examination fee paid 
Examination procedure19.03.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
08.04.1993Examination requested  [1993/30]
28.12.1995Despatch of a communication from the examining division (Time limit: M08)
21.08.1996Reply to a communication from the examining division
03.02.1998Despatch of a communication from the examining division (Time limit: M06)
23.06.1998Reply to a communication from the examining division
24.07.2000Despatch of communication of intention to grant (Approval: No)
14.02.2001Despatch of communication of intention to grant (Approval: later approval)
19.02.2001Communication of intention to grant the patent
02.03.2001Fee for grant paid
02.03.2001Fee for publishing/printing paid
Opposition(s)17.05.2002No opposition filed within time limit [2002/32]
Fees paidRenewal fee
17.09.1993Renewal fee patent year 03
19.09.1994Renewal fee patent year 04
25.09.1995Renewal fee patent year 05
09.10.1996Renewal fee patent year 06
10.10.1997Renewal fee patent year 07
28.10.1998Renewal fee patent year 08
14.10.1999Renewal fee patent year 09
11.10.2000Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]   The New England Journal Of Medicine, Volume 314, No. 21, issued 22 May 1986. EISENBARTH, "Type I Diabetes Mellitus, A Chronic Autoimmune Disease", pages 1360-1368, see entire document. [A]
 [AP]   Science, Volume 252, issued 05 April 1991, MARX, "Testing of Autoimmune Therapy Begins", pages 27-28, see entire document. [AP]
 [A]   Diabetes Care, Volume 13, No. 7, issued July 1990, ZIEGLER et al. "Predicting Type I Diabetes", pages 762-775, see entire article. [A]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.